加拿大批准了第一种无针的阿基因巴胺鼻喷剂用于严重过敏. Canada approves first needle-free epinephrine nasal spray for severe allergies.

加拿大卫生部批准Neffy,这是第一款无针的阿基内林鼻喷剂,用于治疗严重过敏反应. Health Canada has approved Neffy, the first needle-free epinephrine nasal spray, for treating severe allergic reactions. 这种两毫克的治疗方法预计将在2026年夏天上市,为EpiPens等传统注射式自动注射器提供一种非侵入性替代方案. The two-milligram treatment, which is expected to be available by summer 2026, offers a non-invasive alternative to traditional injectable auto-injectors like EpiPens. 对于那些可能害怕针头或难以注射的人来说, 这种喷雾已被批准用于至少30公斤重的个人. The spray is approved for individuals weighing at least 30 kilograms, providing a new option for those who may fear needles or have difficulty administering injections.